A novel, disruptive vaccination technology

Article Properties
  • Language
    English
  • DOI (url)
    10.4161/hv.25181
  • Publication Date
    2013/10/04
  • Journal
    Human Vaccines & Immunotherapeutics
  • Indian UGC (journal)
  • Refrences
    35
  • Citations
    151
  • Karl-Josef Kallen
  • Regina Heidenreich
  • Margit Schnee
  • Benjamin Petsch
  • Thomas Schlake
  • Andreas Thess
  • Patrick Baumhof
  • Birgit Scheel
  • Sven D Koch
  • Mariola Fotin-Mleczek
Cite
Kallen, Karl-Josef, et al. “A Novel, Disruptive Vaccination Technology”. Human Vaccines &Amp; Immunotherapeutics, vol. 9, no. 10, 2013, pp. 2263-76, https://doi.org/10.4161/hv.25181.
Kallen, K.-J., Heidenreich, R., Schnee, M., Petsch, B., Schlake, T., Thess, A., Baumhof, P., Scheel, B., Koch, S. D., & Fotin-Mleczek, M. (2013). A novel, disruptive vaccination technology. Human Vaccines &Amp; Immunotherapeutics, 9(10), 2263-2276. https://doi.org/10.4161/hv.25181
Kallen KJ, Heidenreich R, Schnee M, Petsch B, Schlake T, Thess A, et al. A novel, disruptive vaccination technology. Human Vaccines & Immunotherapeutics. 2013;9(10):2263-76.
Journal Categories
Medicine
Internal medicine
Specialties of internal medicine
Immunologic diseases
Allergy
Medicine
Therapeutics
Pharmacology
Technology
Chemical technology
Biotechnology
Refrences
Title Journal Journal Categories Citations Publication Date
10.1200/JCO.2012.42.3293 2012
Final analysis of a phase I/IIa study with CV9103, an intradermally administered prostate cancer immunotherapy based on self-adjuvanted mRNA. Journal of Clinical Oncology
  • Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
  • Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
  • Medicine: Medicine (General)
 15 2011
Messenger RNA vaccination in NSCLC: Findings from a phase I/IIa clinical trial. Journal of Clinical Oncology
  • Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
  • Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
  • Medicine: Medicine (General)
 17 2011
Vaccines for the twenty-first century society Nature Reviews Immunology
  • Medicine: Internal medicine: Infectious and parasitic diseases
  • Medicine: Internal medicine: Specialties of internal medicine: Immunologic diseases. Allergy
  • Medicine: Internal medicine: Specialties of internal medicine: Immunologic diseases. Allergy
 269 2011
10.1128/MMBR.44.2.175-205.1980 Microbiological Reviews 1980
Citations
Title Journal Journal Categories Citations Publication Date
Advanced nanoscale delivery systems for mRNA-based vaccines Biochimica et Biophysica Acta (BBA) - General Subjects
  • Science: Biology (General)
  • Science: Biology (General)
  • Science: Physics
  • Science: Biology (General)
  • Science: Chemistry: Organic chemistry: Biochemistry
  • Science: Biology (General)
  • Science: Chemistry: Organic chemistry: Biochemistry
 1 2024
Advances, opportunities and challenges in developing therapeutic cancer vaccines Critical Reviews in Oncology/Hematology
  • Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
  • Medicine: Internal medicine: Specialties of internal medicine: Diseases of the blood and blood-forming organs
  • Medicine: Medicine (General)
 2024
What is the relationship between sociotechnical transition and disruptive innovations? Technological Forecasting and Social Change
  • Geography. Anthropology. Recreation: Environmental sciences
  • Social Sciences: Commerce: Business
  • Geography. Anthropology. Recreation: Human ecology. Anthropogeography: Settlements: Cities. Urban geography
  • Social Sciences: Communities. Classes. Races: Urban groups. The city. Urban sociology
  • Political science: Political institutions and public administration (General)
  • Social Sciences
 2024
mRNA vaccines in gastric cancer: How close are we? Vacunas 2024
mRNA vaccines in gastric cancer: How close are we? Vacunas (English Edition) 2024
Citations Analysis
Category Category Repetition
Medicine: Medicine (General)46
Medicine: Internal medicine: Specialties of internal medicine: Immunologic diseases. Allergy46
Science: Biology (General)29
Medicine: Therapeutics. Pharmacology27
Technology: Chemical technology: Biotechnology23
Science: Biology (General): Genetics23
Medicine: Public aspects of medicine: Toxicology. Poisons22
Science: Chemistry: Organic chemistry: Biochemistry19
Medicine16
Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens15
Science: Chemistry: General. Including alchemy14
Science: Chemistry13
Science: Microbiology12
Technology: Electrical engineering. Electronics. Nuclear engineering: Materials of engineering and construction. Mechanics of materials10
Technology: Chemical technology9
Medicine: Medicine (General): Medical technology8
Medicine: Internal medicine: Infectious and parasitic diseases7
Science: Biology (General): Cytology7
Science: Science (General)6
Science: Physics5
Medicine: Pharmacy and materia medica5
Science: Chemistry: Physical and theoretical chemistry3
Medicine: Internal medicine3
Medicine: Public aspects of medicine2
Technology: Chemical technology: Chemical engineering1
Medicine: Internal medicine: Special situations and conditions: Arctic medicine. Tropical medicine1
Geography. Anthropology. Recreation: Environmental sciences1
Social Sciences: Commerce: Business1
Geography. Anthropology. Recreation: Human ecology. Anthropogeography: Settlements: Cities. Urban geography1
Social Sciences: Communities. Classes. Races: Urban groups. The city. Urban sociology1
Political science: Political institutions and public administration (General)1
Social Sciences1
Science: Chemistry: Analytical chemistry1
Medicine: Internal medicine: Specialties of internal medicine: Diseases of the blood and blood-forming organs1
Medicine: Surgery1
Science: Mathematics: Instruments and machines1
Science: Physiology1
The category Medicine: Medicine (General) 46 is the most commonly referenced area in studies that cite this article. The first research to cite this article was titled Landes Highlights and was published in 2013. The most recent citation comes from a 2024 study titled mRNA vaccine designs for optimal adjuvanticity and delivery. This article reached its peak citation in 2023, with 26 citations. It has been cited in 91 different journals, 31% of which are open access. Among related journals, the Vaccines cited this research the most, with 11 citations. The chart below illustrates the annual citation trends for this article.
Citations used this article by year